IKBKG and fatty liver disease: In contrast, IKBKG, also known as NF-κB essential modulator (NEMO), is required for the activation of the NF-κB complex by proinflammatory stimuli, and it has recently been recognized as suppressor of hepatic steatosis, possibly through the negative interaction with PPARs [39]–[42].